<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Patent Insights | DexPatent</provider_name><provider_url>https://dexpatent.com/insights</provider_url><author_name>Linda Raj</author_name><author_url>https://dexpatent.com/insights/author/admin/</author_url><title>Enveric Biosciences receives new patent for neuropsychiatric treatments - Patent Insights | DexPatent</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="283kspeiQR"&gt;&lt;a href="https://dexpatent.com/insights/2026/01/01/enveric-biosciences-gets-new-neuropsychiatric-patent/"&gt;Enveric Biosciences receives new patent for neuropsychiatric treatments&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://dexpatent.com/insights/2026/01/01/enveric-biosciences-gets-new-neuropsychiatric-patent/embed/#?secret=283kspeiQR" width="600" height="338" title="&#x201C;Enveric Biosciences receives new patent for neuropsychiatric treatments&#x201D; &#x2014; Patent Insights | DexPatent" data-secret="283kspeiQR" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://dexpatent.com/insights/wp-includes/js/wp-embed.min.js
/* ]]&gt; */
&lt;/script&gt;
</html><thumbnail_url>https://dexpatent.com/insights/wp-content/uploads/2026/01/enveric-header-v1.png</thumbnail_url><thumbnail_width>760</thumbnail_width><thumbnail_height>450</thumbnail_height><description>Enveric Biosciences receives new patent for neuropsychiatric treatments Enveric Biosciences has received patent that discloses novel molecules with potential applications for mental health disorders. The patent discloses compounds based on known substances with relevant pharmacological activity but chemically altered to potentially improve efficacy and reduce side effects. (Source &#x2013; Ng.investing) [&hellip;]</description></oembed>
